T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$2.31B |
| 2 |
Apple
AAPL
|
+$1.58B |
| 3 |
Sherwin-Williams
SHW
|
+$1.37B |
| 4 |
HubSpot
HUBS
|
+$1.32B |
| 5 |
Kenvue
KVUE
|
+$1.25B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$4.37B |
| 2 |
Lam Research
LRCX
|
+$1.54B |
| 3 |
Applied Materials
AMAT
|
+$1.33B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.19B |
| 5 |
Halliburton
HAL
|
+$1.16B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.32% |
| 2 | Healthcare | 15.15% |
| 3 | Financials | 10.54% |
| 4 | Consumer Discretionary | 10.48% |
| 5 | Communication Services | 8.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1626
Pennant Group
PNTG
$1.36B
| $2.02M | ﹤0.01% |
56,634
-36,964
| -39% | -$1.14M |
|
1627
First Merchants
FRME
$2.74B
| $2.02M | ﹤0.01% |
54,297
+1,596
| +3% | +$59.1K |
|
1628
Immuneering
IMRX
$326M
| $2.02M | ﹤0.01% |
810,127
-49,247
| -6% | -$71.6K |
|
1629
First Financial Bancorp
FFBC
$3.61B
| $2.01M | ﹤0.01% |
79,658
+861
| +1% | +$21.6K |
|
1630
Grab
GRAB
$14.9B
| $2.01M | ﹤0.01% |
528,330
+34,933
| +7% | +$119K |
|
1631
Harmonic Inc
HLIT
$1.51B
| $2M | ﹤0.01% |
137,588
-1,520
| -1% | -$20.3K |
|
1632
ICF International
ICFI
$1.59B
| $2M | ﹤0.01% |
11,988
+157
| +1% | +$24.1K |
|
1633
iShares Russell 2000 ETF
IWM
$82.6B
| $1.99M | ﹤0.01% |
9,010
+714
| +9% | +$153K |
|
1634
Eastern Bankshares
EBC
$5.4B
| $1.98M | ﹤0.01% |
120,883
+15,685
| +15% | +$248K |
|
1635
Hims & Hers Health
HIMS
$6.75B
| $1.98M | ﹤0.01% |
107,440
-87,997
| -45% | -$1.58M |
|
1636
RxSight
RXST
$295M
| $1.98M | ﹤0.01% |
40,047
+2,840
| +8% | +$146K |
|
1637
Global E Online
GLBE
$7.14B
| $1.98M | ﹤0.01% |
51,446
+2,384
| +5% | +$83.9K |
|
1638
PJT Partners
PJT
$4.48B
| $1.97M | ﹤0.01% |
14,763
-2,077
| -12% | -$254K |
|
1639
COPT Defense Properties
CDP
$4.23B
| $1.96M | ﹤0.01% |
64,712
+1,575
| +2% | +$44.8K |
|
1640
Surgery Partners
SGRY
$2.01B
| $1.96M | ﹤0.01% |
60,817
-319,189
| -84% | -$9.43M |
|
1641
Myers Industries
MYE
$1.23B
| $1.96M | ﹤0.01% |
141,489
+5,795
| +4% | +$81.9K |
|
1642
Resideo Technologies
REZI
$3.06B
| $1.95M | ﹤0.01% |
96,970
+3,596
| +4% | +$71.3K |
|
1643
Astrana Health
ASTH
$1.98B
| $1.95M | ﹤0.01% |
33,661
+986
| +3% | +$48.4K |
|
1644
CVB Financial
CVBF
$4.1B
| $1.95M | ﹤0.01% |
109,262
-688
| -0.6% | -$12.3K |
|
1645
iShares Core S&P Mid-Cap ETF
IJH
$128B
| $1.95M | ﹤0.01% |
31,246
| – | – |
|
1646
Sylvamo
SLVM
$1.54B
| $1.95M | ﹤0.01% |
22,670
+893
| +4% | +$66.7K |
|
1647
Atlantic Union Bankshares
AUB
$6.12B
| $1.95M | ﹤0.01% |
51,652
-5,480
| -10% | -$206K |
|
1648
Liberty Media Series A
FWONA
$24.1B
| $1.94M | ﹤0.01% |
27,170
+780
| +3% | +$54.7K |
|
|
TGI
1649
DELISTED
Triumph Group
TGI
| $1.94M | ﹤0.01% |
150,573
-52,269
| -26% | -$758K |
|
1650
Transocean
RIG
$6.5B
| $1.94M | ﹤0.01% |
455,881
-1,512
| -0.3% | -$7.46K |
|
Similar funds
T. Rowe Price Associates's Q3 2024 Portfolio in Review
As of Q3 2024, T. Rowe Price Associates held 3,059 positions worth $869B, up 3.9% from $836B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Trading was light in Q3 2024: portfolio turnover was 4.3%. T. Rowe Price Associates opened 82 new positions and exited 51, leaving the 3,059-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 34% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q3 2024 buy was Lineage Inc: 4,699,854 shares worth $368M.
- T. Rowe Price Associates added most to Advanced Micro Devices in Q3 2024, an estimated $2.31B increase.
- T. Rowe Price Associates's biggest Q3 2024 reduction was NVIDIA, cutting an estimated $4.37B.
- T. Rowe Price Associates fully exited Morphic Holding, Inc. Common Stock in Q3 2024, selling an estimated $75.2M.
- T. Rowe Price Associates's ten largest holdings make up 34% of its $869B portfolio in Q3 2024.
- T. Rowe Price Associates opened 82 new positions and closed 51 in Q3 2024.
- T. Rowe Price Associates's portfolio value rose 3.9% quarter-over-quarter to $869B.
Based on T. Rowe Price Associates's 13F filing for Q3 2024, filed 14 Nov 2024.